SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-044010
Filing Date
2012-08-09
Accepted
2012-08-09 15:50:32
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v318656_10q.htm 10-Q 703135
2 CERTIFICATION v318656_ex31-1.htm EX-31.1 10731
3 CERTIFICATION v318656_ex31-2.htm EX-31.2 10619
4 CERTIFICATION v318656_ex32-1.htm EX-32.1 4528
5 CERTIFICATION v318656_ex32-2.htm EX-32.2 4359
  Complete submission text file 0001144204-12-044010.txt   6111068

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scmp-20120630.xml EX-101.INS 920373
7 XBRL TAXONOMY EXTENSION SCHEMA scmp-20120630.xsd EX-101.SCH 51627
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scmp-20120630_cal.xml EX-101.CAL 76673
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scmp-20120630_def.xml EX-101.DEF 332454
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scmp-20120630_lab.xml EX-101.LAB 419685
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scmp-20120630_pre.xml EX-101.PRE 391671
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 121020290
SIC: 2834 Pharmaceutical Preparations